ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

25,712Medicare Part D Prescriptions Filled, Including Refills

Rank: 25 out of 2343

$1.2M Total Retail Price of All Prescriptions

Rank: 56 out of 2343

841 Patients Receiving at Least One Drug in Part D
84%Patients 65 Years and Older
42% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Pennsylvania
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 841 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

16% of this provider’s 841 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

1% of this provider’s 22,132 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$47 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

31 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Pennsylvania
LEVOTHYROXINE SODIUM 1,264 1,127 1 2
OMEPRAZOLE 872 716 2 4
WARFARIN SODIUM 839 792 3 8
SIMVASTATIN 831 702 4 1
METOPROLOL TARTRATE 802 708 5 7
AMLODIPINE BESYLATE 728 672 6 5
FUROSEMIDE 636 571 7 6
HYDROCODONE-ACETAMINOPHEN 616 474 S3 8 13
METOPROLOL SUCCINATE 581 541 9 14
PRAVASTATIN SODIUM 495 434 10 15
LISINOPRIL 491 410 11 3
ATORVASTATIN CALCIUM 454 421 12 10
METFORMIN HCL 351 288 13 9
LOSARTAN POTASSIUM 339 310 14 19
POTASSIUM CHLORIDE 334 298 15 18
DONEPEZIL HCL 315 310 16 21
SERTRALINE HCL 313 293 17 20
PREDNISONE 310 259 18 37
CRESTOR 275 248 19 30
NEXIUM 270 233 20 33
CITALOPRAM HBR 258 236 21 17
FELODIPINE ER 239 236 22 116
DIGOXIN 230 222 23 35
LOSARTAN-HYDROCHLOROTHIAZIDE 223 206 24 64
ZOLPIDEM TARTRATE 222 137 25 24
FLUOXETINE HCL 211 167 26 82
ISOSORBIDE MONONITRATE ER 209 198 27 32
CLOPIDOGREL 207 199 28 26
PANTOPRAZOLE SODIUM 204 170 29 22
DIOVAN 203 190 30 23
GABAPENTIN 201 141 31 16
TRIAMTERENE-HCTZ 185 173 32 57
PAROXETINE HCL 180 163 33 66
GLIPIZIDE 179 131 34 56
MELOXICAM 173 126 35 68
ALLOPURINOL 173 144 35 31
RANITIDINE HCL 170 152 37 43
CYMBALTA 166 146 38 74
HYDROCHLOROTHIAZIDE 163 150 39 11
GLIPIZIDE XL 159 158 40 84
GEMFIBROZIL 157 122 41 133
PLAVIX 155 144 42 38
NAMENDA 148 148 43 36
JANUVIA 145 105 44 50
ESCITALOPRAM OXALATE 144 143 45 55
AZITHROMYCIN 140 108 46 39
LEVOFLOXACIN 136 100 47 106
SYNTHROID 128 108 48 40
MIRTAZAPINE 128 117 48 41
ADVAIR DISKUS 127 112 50 34
VENLAFAXINE HCL ER 123 97 51 87
VERAPAMIL ER 117 106 52 95
RISPERIDONE 116 95 53 61
DILTIAZEM 24HR ER 113 110 54 76
AMOXICILLIN 113 96 54 118
GLIMEPIRIDE 112 112 56 45
SULFAMETHOXAZOLE-TRIMETHOPRIM 109 91 57 120
FLUTICASONE PROPIONATE 108 95 58 46
TAMSULOSIN HCL 106 90 59 29
BENICAR 106 106 59 93
FAMOTIDINE 106 98 59 60
AMOX TR-POTASSIUM CLAVULANATE 105 77 62 160
LIPITOR 99 88 63 78
LIDODERM 98 86 64 130
AMLODIPINE BESYLATE-BENAZEPRIL 95 95 65 59
LANTUS 94 84 66 51
ENALAPRIL MALEATE 92 92 67 58
ALENDRONATE SODIUM 90 90 68 28
CEFUROXIME 87 72 69 193
IBUPROFEN 86 44 70 75
TRAMADOL HCL 83 69 71 25
SPIRONOLACTONE 82 73 72 65
AMITRIPTYLINE HCL 81 80 R 73 117
OLANZAPINE 79 79 74 121
ATENOLOL 79 74 74 12
LOVASTATIN 77 60 76 47
CLONIDINE HCL 75 73 77 70
MECLIZINE HCL 73 60 78 103
CIPROFLOXACIN HCL 73 68 78 72
CELEBREX 72 71 80 71
PROAIR HFA 72 32 80 86
POLYETHYLENE GLYCOL 3350 71 68 82 54
KLOR-CON M10 71 71 82 107
OXYCODONE-ACETAMINOPHEN 71 58 S2 82 49
CEPHALEXIN 69 60 85 111
CYCLOBENZAPRINE HCL 68 19 R 86 109
QUINAPRIL HCL 68 66 86 73
DILTIAZEM 24HR CD 67 67 88 83
CARVEDILOL 67 56 88 27
TERAZOSIN HCL 67 67 88 143
PROPRANOLOL HCL 66 63 91 132
TRAZODONE HCL 63 15 92 53
TRIAMCINOLONE ACETONIDE 62 62 93 137
LEVOXYL 61 61 94 237
DETROL LA 60 60 95 150
NAPROXEN SODIUM 59 41 96 408
AGGRENOX 59 59 96 174
LEXAPRO 58 55 98 178
BUPROPION HCL SR 58 20 98 221
CARBIDOPA-LEVODOPA 58 58 98 85
DIVALPROEX SODIUM 58 58 98 105
CLOTRIMAZOLE-BETAMETHASONE 56 50 102 127
LACTULOSE 56 49 102 139
OXYCODONE HCL-ACETAMINOPHEN 56 23 S2 102 136
NASONEX 55 36 105 209
LYRICA 55 39 105 135
SPIRIVA 54 53 107 48
GLIPIZIDE ER 53 37 108 115
COMBIVENT 52 34 109 144
TRIAMTERENE-HYDROCHLOROTHIAZID 52 41 109 263
RAMIPRIL 51 51 111 90
DILTIAZEM ER 50 47 112 207
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 3, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.